Diana(Dogaru)BarbMD

PubMed

• The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis.
  Layla A Abushamat, Pir Ahmad Shah, Robert H Eckel, Stephen A Harrison, Diana Barb> ;Clinical Gastroenterology and Hepatology. 2024 Feb 15
• Clinician feedback using a shared decision-making tool for the evaluation of patients with thyroid nodules-an observational study.
  Naykky Singh Ospina, Chandani Patel Chavez, Eddison Godinez Leiva, Diliara Bagautdinova, Jessica Hidalgo, Sandra Hartasanchez, Sandra Algarin Perneth, Diana Barb, Deep...> ;Endocrine. 2024 Feb 1
• 246 citations
  AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.
  Mary E Rinella, Brent A Neuschwander-Tetri, Mohammad Shadab Siddiqui, Manal F Abdelmalek, Stephen Caldwell, Diana Barb, David E Kleiner, Rohit Loomba> ;Hepatology. 2023 May 1
• 2 citations
  Patient feedback receiving care using a shared decision making tool for thyroid nodule evaluation-an observational study.
  Chandani Patel Patel Chavez, Eddison Godinez Leiva, Diliara Bagautdinova, Jessica Hidalgo, Sandra Hartasanchez, Diana Barb, Deepa Danan, Peter Dziegielewski, Catherine...> ;Endocrine. 2023 Apr 1
• Body Fat Distribution in Lean Individuals with Metabolic Abnormalities.
  Rodrigo J Valderrábano, Juliana Ferri-Guerra, Diana Barb, Rajesh Garg, Badour, S.> ;Metabolic Syndrome and Related Disorders. 2023 Mar 1
• 9 citations
  Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.
  Srilaxmi Kalavalapalli, Eddison Godinez Leiva, Romina Lomonaco, Xiaofei Chi, Sulav Shrestha, Rachel Dillard, Jeffery Budd, Jessica Portillo Romero, Christina Li, Ferna...> ;The Journal of Clinical Endocrinology and Metabolism. 2023 Apr 13
• 253 citations
  American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and End...
  Kenneth Cusi, Scott Isaacs, Diana Barb, Rita Basu, Sonia Caprio, W Timothy Garvey, Sangeeta Kashyap, Jeffrey I Mechanick, Marialena Mouzaki, Karl Nadolsky, Mary E Rine...> ;Endocrine Practice. 2022 May 1
• Response to: "Nonalcoholic fatty liver disease in diabetes: Overlooked or just ignored?"
  Diana Barb, Kenneth Cusi> ;Obesity. 2022 May 1
• Prevalence and Characteristics of Hyperthyroidism Among Patients With Sarcoidosis in the United States.
  Farah Amer, Bashar N Alzghoul, Arroj Ali, Saminder S Kalra, Ayoub Innabi, Bara Alzghoul, Sarah Ghaith, Tamara Al-Hakim, Diana M Gomez, Diana Barb, Whitney W Woodmansee...> ;Endocrine Practice. 2022 Jul 1
• 7 citations
  Development and pilot testing of a conversation aid to support the evaluation of patients with thyroid nodules.
  Naykky Singh Ospina, Diliara Bagautdinova, Ian Hargraves, Diana Barb, Sreevidya Subbarayan, Ashok Srihari, Shu Wang, Spyridoula Maraka, Carma L. Bylund, Debbie Treise,...> ;Clinical Endocrinology. 2021 Sep 29
• 58 citations
  Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease
  Diana Barb, Enrico Repetto, Michael E Stokes, Sudha Shankar, Kenneth Cusi> ;Obesity. 2021 Sep 23
• 46 citations
  PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH.
  Amalia Gastaldelli, S. Sabatini, Fabrizia Carli, Melania Gaggini, Fernando Bril, Renata Belfort-DeAguiar, Vincenzo Positano, Diana Barb, Sushma Kadiyala, Stephen A. Ha...> ;Liver International. 2021 Jul 5
• 4 citations
  Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes.
  Fernando Bril, Michael J. McPhaul, Srilaxmi Kalavalapalli, Romina Lomonaco, Diana Barb, Meagan Gray, Dov Shiffman, Charles M. Rowland, Kenneth Cusi> ;The Journal of Clinical Endocrinology and Metabolism. 2021 Oct 21
• 6 citations
  Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes
  Kristin Dayton, Fernando Bril, Diana Barb, Jinping Lai, Srilaxmi Kalavalapalli, Kenneth Cusi> ;Plos One. 2021 Jun 2
• 145 citations
  Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening.
  Romina Lomonaco, Eddison Godinez Leiva, Fernando Bril, Sulav Shrestha, Lydia Mansour, Jeff Budd, Jessica Portillo Romero, Siegfried Schmidt, Ku-Lang Chang, George P. N...> ;Diabetes Care. 2021 Feb 1
• 8 citations
  Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide regis...
  Bashar Alzghoul, Farah Amer, Diana Barb, Ayoub Innabi, Mamoun T. Mardini, Chen Bai, Bara Alzghoul, Tamara Al-Hakim, Noopur Singh, Mindy Buchanan, Leslie Serchuck, Dian...> ;ERJ Open Research. 2021 Jan 1
• 3 citations
  Adult hypophosphatasia manifests in a marathon runner.
  Nada Fanous, Diana Barb> ;BMJ Case Reports. 2020 Sep 1
• 36 citations
  Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis.
  Fernando Bril, Diana Barb, Romina Lomonaco, Jinping Lai, Kenneth Cusi> ;Journal of Hepatology. 2020 Mar 1
• 53 citations
  Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes
  Diana Barb, Fernando Bril, Srilaxmi Kalavalapalli, Kenneth Cusi> ;The Journal of Clinical Endocrinology and Metabolism. 2019 Aug 1
• Profound Hypoglycemia in a Hospitalized Patient: Paraneoplastic Insulin-Like Growth Factor.
  George Cockey, Angela Fernandez-Manovel, Josue Hernandez, Andrea Ramirez, Diana Barb> ;The American Journal of Medicine. 2019 Jun 23
• 28 citations
  Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes
  Fernando Bril, Diana Julie Leeming, Morten A. Karsdal, Srilaxmi Kalavalapalli, Diana Barb, Jinping Lai, Matthew Rabe, Kenneth Cusi> ;Diabetes Care. 2019 May 21
• 96 citations
  Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
  Kenneth Cusi, Fernando Bril, Diana Barb, David Polidori, Sue Sha, Atalanta Ghosh, Kristin Farrell, Nishanth E. Sunny, Srilaxmi Kalavalapalli, Jeremy Pettus, Theodore P...> ;Diabetes, Obesity & Metabolism. 2019 Apr 1
• 28 citations
  Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trial.
  Paola Portillo-Sanchez, Fernando Bril, Romina Lomonaco, Diana Barb, Beverly Orsak, Jan M. Bruder, Kenneth Cusi> ;Journal of Diabetes. 2019 Mar 1
• 9 citations
  Inpatient Glucose Values: Determining the Nondiabetic Range and Use in Identifying Patients at High Risk for Diabetes.
  Mary K. Rhee, Sandra E. Safo, Sandra L. Jackson, Wenqiong Xue, Darin E. Olson, Qi Long, Diana Barb, J. Sonya Haw, Anne Tomolo, Lawrence S. Phillips> ;The American Journal of Medicine. 2017 Oct 6
• 159 citations
  Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
  Fernando Bril, Diana Barb, Paola Portillo-Sanchez, Diane Biernacki, Romina Lomonaco, Amitabh Suman, Michelle H. Weber, Jeffrey Budd, Maria Elisa Lupi, Kenneth Cusi> ;Hepatology. 2017 Apr 1
• Join now to see all

Journal Articles

• Effect of Canagliflozin Treatment on Hepatic Triglyceride Content and Glucose Metabolism in Patients with Type 2 Diabetes  
  Diana Barb, Sunder Mudaliar, Kenneth Cusi, Diabetes, Obesity and Metabolism

Lectures

• Novel Approaches to Diabetes Management 
  ENDO 2019 - New Orleans, LA - 3/24/2019
• Guided Posters: Diabetes and Glucose Metabolism 
  ENDO 2019 - New Orleans, LA - 3/24/2019
• Guided Posters: Reproductive Endocrinology 
  ENDO 2019 - New Orleans, LA - 3/24/2019